2018 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Co-Stimulation Based Regimens
Date: Sunday, June 3, 2018
Time: 4:30pm-6:00pm
Location: Room 6C
Session Type: Concurrent Session
Meeting: 2018 American Transplant Congress
- 4:30pm-4:42pm
Immunophenotype of Cells Infiltrating the Graft Explains the Benefits of Belatacept
J. Furuzawa-Carballeda,1 N. Uribe-Uribe,2 G. Mondragon-Ramirez,4 J. Arreola-Guerra,5 R. Reyes-Acevedo,5 M. Vilatoba,3 R. Chavez-Fernandez,1 F. Lopez-Verdugo,1 A. Lopez-Toledo,4 G. Mondragon-Salgado,4 J. Alberu.3
- 4:42pm-4:54pm
The BEST Trial: A Prospective Randomized Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression
E. Woodle,1 D. Kaufman,2 A. Shields,1 J. Leone,3 A. Wiseman,4 A. Matas,5 P. West-Thielke,6 E. King,1 R. Alloway.1
- 4:54pm-5:06pm
Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients
S. Sethi, J. Choi, A. Vo, A. Peng, K. Lim, R. Najjar, S. Jordan, E. Huang.
- 5:06pm-5:18pm
Belatacept Maintenance Immunosuppression Use and Outcomes in the Real-World Clinical Setting Using OPTN/UNOS Kidney Transplant Registry
S. Sanoff,1 K. Ravindra,1 W. Irish.1,2
- 5:18pm-5:30pm
Belatacept in Kidney Transplant Recipients with Preformed Donor Specific Anti-HLA Antibodies: Results of the BELACOR Trial
C. Leibler,1 F. Canoui,2 M. Matignon,1 E. Rondeau,3 A. Zarour,2 A. Durrbach,4 S. Malard,5 P. Grimbert.1
- 5:30pm-5:42pm
Tissue Talks: Graft´s Histological Findings 10 Years after Belatacept or CNI
G. Mondragon-Ramirez,1 N. Uribe-Uribe,2 J. Arreola-Guerra,5 R. Reyes-Acevedo,5 M. Vilatoba,3 J. Furuzawa-Carballeda,4 A. Lopez-Toledo,1 G. Mondragon-Salgado,1 J. Alberu.3
- 5:42pm-5:54pm
Precision Medicine for Determining the Efficacy of a Novel Belatacept Regimen
J. Shoji, J. Leung, E. Tavares, Q. Tang, F. Vincenti.
« View all sessions from the 2018 American Transplant Congress